Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90301-90350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05822271
Evaluation of Surgical Outcomes of Patients Treated With the Surgery First Approach and Aligners
NARecruiting
20 participants
Started: Jan 30, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05528380
Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use
NARecruiting
50 participants
Started: Jan 30, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT05175417
Visualization of Neural Targets With 3T MRI
N/ARecruiting
40 participants
Started: Jan 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05171972
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
N/AActive, not recruiting
40 participants
Started: Jan 29, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05063032
Left Atrial FLUTter: a Comparison of Ablation Guided by High-density MApping and Empirical LINEar Ablation.
NARecruiting
100 participants
Started: Jan 28, 2022 · Completed: Oct 1, 2024
1 condition1 sponsor1 location
NCT05213806
WithHolding Enteral Feeds Around Blood Transfusion (International)
NARecruiting
4,333 participants
Started: Jan 28, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06329466
The Effect of Emotional Freedom Technique (EFT) on Pain Intensity and Menstruation Symptoms
N/AActive, not recruiting
48 participants
Started: Jan 28, 2022 · Completed: Jul 25, 2024
1 condition2 sponsors1 location
NCT06847295
Epidural Electrical Stimulation to Restore Standing and Walking in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Study on Motor Recovery, Spasticity Reduction, and Quality of Life Improvement Through Neuromodulation and Intensive Rehabilitation
NARecruiting
10 participants
Started: Jan 28, 2022 · Completed: Jan 10, 2027
2 conditions2 sponsors1 location
NCT06352502
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
N/ARecruiting
30 participants
Started: Jan 28, 2022 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT05065294
Psilocybin Therapy for Depression in Bipolar II Disorder
PHASE2Active, not recruiting
14 participants
Started: Jan 28, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT04765098
Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
PHASE2Recruiting
60 participants
Started: Jan 28, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT04870944
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
PHASE1/PHASE2Recruiting
63 participants
Started: Jan 28, 2022 · Completed: Dec 31, 2026
10 conditions2 sponsors34 locations
NCT06945731
The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Weight Loss in Overweight and Obese Patients
NAActive, not recruiting
50 participants
Started: Jan 28, 2022 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT05362903
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting
N/AActive, not recruiting
1,854 participants
Started: Jan 28, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor122 locations
NCT05064865
Impact of Regular Consumption of Grapes on Eye Health in Singapore Older Adults
NAActive, not recruiting
34 participants
Started: Jan 28, 2022 · Completed: Oct 31, 2024
2 conditions3 sponsors1 location
NCT04816773
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
N/AEnrolling by invitation
150 participants
Started: Jan 27, 2022 · Completed: Jan 31, 2035
4 conditions1 sponsor2 locations
NCT05026632
NPI-002 Intravitreal Implant for the Delay of Cataract Progression
PHASE1/PHASE2Recruiting
30 participants
Started: Jan 27, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05139095
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
PHASE2Recruiting
70 participants
Started: Jan 27, 2022 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT04980833
Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)
PHASE2Active, not recruiting
41 participants
Started: Jan 27, 2022 · Completed: Jul 22, 2027
1 condition1 sponsor6 locations
NCT05231993
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening
NAEnrolling by invitation
280 participants
Started: Jan 27, 2022 · Completed: Dec 31, 2029
1 condition3 sponsors1 location
NCT05293366
LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
N/ARecruiting
100 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2027
1 condition2 sponsors1 location
NCT05369065
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
PHASE1Recruiting
60 participants
Started: Jan 27, 2022 · Completed: Jan 31, 2029
2 conditions2 sponsors3 locations
NCT05241392
Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
PHASE1Active, not recruiting
30 participants
Started: Jan 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05165446
Novel MRE Technique to Assess a Risk Factor for Liver Cancer
N/AActive, not recruiting
35 participants
Started: Jan 27, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05898711
Kerecis Case Registry for SurgiBind : Soft Tissue Reinforcement
N/AActive, not recruiting
200 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2026
1 condition1 sponsor1 location
NCT04687215
Diabetic Neuropathy in Spinal Cord Stimulator Patients
N/ARecruiting
25 participants
Started: Jan 27, 2022 · Completed: Dec 1, 2026
7 conditions1 sponsor1 location
NCT05318183
Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components
NAActive, not recruiting
65 participants
Started: Jan 27, 2022 · Completed: May 30, 2026
4 conditions2 sponsors1 location
NCT05194345
An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD
NAActive, not recruiting
51 participants
Started: Jan 27, 2022 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT04941937
Selinexor in Combination With Immunomodulator (Thalidomide/Pomalidomide/Lenalidomide)in RRMM
PHASE2Recruiting
90 participants
Started: Jan 27, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05379556
LOng COvid COmorbidities: Andrological, Reproductive, Sexual Dysfunctions in Patients Recovered From COVID-19
N/ARecruiting
100 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2027
1 condition2 sponsors1 location
NCT04823624
MBG453 in Lower Risk MDS
PHASE2Active, not recruiting
20 participants
Started: Jan 27, 2022 · Completed: Nov 1, 2026
1 condition2 sponsors3 locations
NCT04894188
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
NARecruiting
38 participants
Started: Jan 27, 2022 · Completed: Jul 1, 2041
1 condition1 sponsor2 locations
NCT04796220
Focused Ultrasound and Gemcitabine in Breast Cancer
PHASE1Recruiting
32 participants
Started: Jan 27, 2022 · Completed: Feb 28, 2030
2 conditions1 sponsor1 location
NCT06833229
Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma
N/ARecruiting
200 participants
Started: Jan 27, 2022 · Completed: Jan 27, 2031
1 condition1 sponsor1 location
NCT05082961
Circulating Immunes Cells, Cytokines and Brain Radiotherapy
NARecruiting
40 participants
Started: Jan 27, 2022 · Completed: Oct 31, 2028
1 condition4 sponsors1 location
NCT05156268
A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
PHASE2Active, not recruiting
26 participants
Started: Jan 27, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors7 locations
NCT05130138
Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia
NARecruiting
100 participants
Started: Jan 27, 2022 · Completed: Nov 1, 2026
1 condition2 sponsors1 location
NCT05198804
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
PHASE1/PHASE2Active, not recruiting
117 participants
Started: Jan 27, 2022 · Completed: May 31, 2025
4 conditions1 sponsor20 locations
NCT05251259
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
PHASE2Active, not recruiting
622 participants
Started: Jan 27, 2022 · Completed: Jan 29, 2026
1 condition1 sponsor267 locations
NCT05016258
"Performance and Safety Use of the Mono Block Implant KONTACT MB"
N/ARecruiting
159 participants
Started: Jan 26, 2022 · Completed: Oct 31, 2025
4 conditions1 sponsor1 location
NCT07062549
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
PHASE1Recruiting
6 participants
Started: Jan 26, 2022 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT05338060
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
N/AActive, not recruiting
10 participants
Started: Jan 26, 2022 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT05306561
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NARecruiting
30 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2023
2 conditions2 sponsors1 location
NCT06806813
Italian Anderson Fabry Disease Cardiovascular Registry
N/ARecruiting
800 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor54 locations
NCT04845828
Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer
NARecruiting
810 participants
Started: Jan 26, 2022 · Completed: Dec 1, 2029
1 condition1 sponsor1 location
NCT06760260
Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia
EARLY_PHASE1Recruiting
7 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04919382
Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
PHASE2Recruiting
56 participants
Started: Jan 26, 2022 · Completed: Dec 31, 2026
6 conditions2 sponsors5 locations
NCT06325098
Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome
NARecruiting
150 participants
Started: Jan 26, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05202210
Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome
N/ARecruiting
100 participants
Started: Jan 26, 2022 · Completed: Jan 26, 2032
1 condition1 sponsor1 location
NCT05334823
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
PHASE2Recruiting
100 participants
Started: Jan 26, 2022 · Completed: Jul 1, 2025
3 conditions1 sponsor10 locations